Skip to main content
Show — Main navigation
Hide — Main navigation
Home
About
The Chair
Inquiry Team
Expert Groups
Inquiry Intermediaries
Core Participants
Legal Representatives
Financial Reports
Approach
Terms of reference
List of Issues
Statements of approach
Inquiry Principles
News
News
Newsletter Archive
Reports
The Inquiry Report
Additional Compensation Report
First Interim Report
Second Interim Report
Compensation Framework Study
Evidence
Evidence
Hearings Archive
Compensation
Support
NHS Psychological Support
Confidential Psychological Support
Support Groups
Infected Blood Support Schemes
Treatment and aftercare
Medical Evidence
Expenses Guidance
Contact us
Search
Accessibility Tool
Zoom in
Zoom out
Reset
Contrast
Accessibility tool
Listen
Get in touch
Quick Exit
Subscribe to Search results
Search
Sort your search results
Relevance
Title
Changed
Inflation had exceeded 20% in 1975; and GDP had declined in both 1973 and 1975. Unemployment had peaked in 1976 at 1.5 million.
Published on:
30 August, 2024
Public expenditure increased in 1978-79.
Published on:
30 August, 2024
Oxford was known to provide a greater quantity of clotting factors than most if not all of the other centres at the time.
Published on:
30 August, 2024
Figure for the annual consumption of Factor 8 in the UK 23 August 1999.
Published on:
30 August, 2024
Figure showing annual consumption of CFC 1976 to 1994.
Published on:
30 August, 2024
Dr Walford understood from her visit to PFC that Liberton had a substantial capacity for expansion notwithstanding substantial staffing difficulties.
Published on:
30 August, 2024
For years, it was considered that because domestic blood products were manufactured by agents of the Crown, Crown immunity rendered domestic products free of similar controls.
Published on:
30 August, 2024
Mr Wormald favoured the expansion of PFC as well as rebuilding Elstree.
Published on:
30 August, 2024
A paper by the Economic Advisors' Office concluded that the most economic option available to meet the NBS' demand for blood products was to redevelop BPL.
Published on:
30 August, 2024
A briefing paper on Blood Products Laboratory Redevelopment said that "Given that the present BPL has to be redeveloped ... it would be more expensive to build a smaller BPL (£18.6 million) and invest £4 million in PFC than to build a BPL capable of achieving self-sufficiency (£21.03 million)."
Published on:
25 October, 2024
Lord Owen described that a major motivating factor was to ensure the safety of the patient. He had in mind the dangers of hepatitis, and the increased risks of this posed by the pool sizes used by commercial companies.
Published on:
30 August, 2024
Freeze-dried fractions made from human blood were developed by Kekwick and Wolf, Soulier, Blombäck and others.
Published on:
30 August, 2024
Dr Antonio Fernández-Montoya argued in a paper that blood donation was an example of genuine altruism where the altruistic behaviour was incorporated into the self as a role.
Published on:
30 August, 2024
John Canavan wrote to the Scottish Home and Health Department to notify them of the decision to undertake a pilot testing study of anti-HCV screening.
Published on:
09 September, 2024
Dr Gunson circulated a report on Phase I of the multi-centre anti-HCV trial to Dr Rejman for the attention of the ACVSB.
Published on:
09 September, 2024
In a letter from Dr Peter Kernoff to Dr Brian Colvin, NANBH was described as a serious disease with significant long-term consequences.
Published on:
09 September, 2024
NANBH was described as already becoming "a major source of concern" in a minute regarding the establishment of an advisory group on viral hepatitis.
Published on:
09 September, 2024
In a brief circulated by Dr Metters in advance of an ACVSB meeting, he noted that the main issue for the Committee in relation to non-A non-B Hepatitis was "whether the time is right to make a decision about adopting the Chiron test".
Published on:
09 September, 2024
Dr Pickles wrote to Dr Rejman and John Canavan emphasising that they "must not delay in seeking help elsewhere in the department in refining our assessment of the cost-benefit of hepatitis C screening."
Published on:
09 September, 2024
Dr Metters asked Dr Rejman and John Canavan to provide "the best available data on the sensitivity, specificity and predictive value of the Ortho and RIBA tests".
Published on:
09 September, 2024
Pagination
First page
First
Previous page
Previous
…
Page
2132
Page
2133
Page
2134
Page
2135
Current page
2136
Page
2137
Page
2138
Page
2139
Page
2140
…
Next page
Next
Last page
Last